跳至主要内容
临床试验/EUCTR2016-002105-18-FI
EUCTR2016-002105-18-FI进行中(未招募)1 期

aboratory measurement of direct oral anticoagulants on patients with atrial fibrillation - Laboratory measurement of anticoagulants dabigatran, rivaroxaban, apixaban and edoxaban.

Helsinki City Hospital Haartman0 个研究点开始时间: 2016年10月19日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • •Patients who present with atrial fibrillation.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range 50
  • •F.1.3 Elderly (>=65 years) yes
  • •F.1.3.1 Number of subjects for this age range 100

排除标准

  • •Valvular atrial fibrillation (mechanical heart valve or mitral stenosis), active malignancy, contraindication to anticoagulation (eg. severe bleeding tendency), severe thrombophilia (eg. lupus anticoagulant).

研究者

发起方
Helsinki City Hospital Haartman

相似试验